These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6193521)

  • 1. Further characterization of HLA-DS molecules: implications for studies assessing the role of human Ia molecules in cell interactions and disease susceptibility.
    Goyert SM; Silver J
    Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5719-23. PubMed ID: 6193521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DS molecules and their relation to supertypic specificities.
    Goyert SM; Moriuchi J; Winchester R; Silver J
    Hum Immunol; 1983 Sep; 8(1):53-63. PubMed ID: 6195135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary structural variation among serologically indistinguishable DS antigens: the MB3-bearing molecule in DR4 cells differs from the MB3-bearing molecule in DR5 cells.
    Giles RC; Hurley CK; Capra JD
    J Immunol; 1984 Jul; 133(1):1-3. PubMed ID: 6609970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
    Maeda H; Hirata R
    J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular specificities of DS-specific reagents: an MB3-like monoclonal antibody isolates two DS molecules.
    Karr RW
    Hum Immunol; 1985 Mar; 12(3):177-83. PubMed ID: 2579937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and functional evidence that an MT3 supertypic determinant defined by a monoclonal antibody is carried on the DR molecule on HLA-DR7 cell lines.
    Horibe K; Flomenberg N; Pollack MS; Adams TE; Dupont B; Knowles RW
    J Immunol; 1984 Dec; 133(6):3195-202. PubMed ID: 6208273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity.
    Giles RC; Nunez G; Hurley CK; Nunez-Roldan A; Winchester R; Stastny P; Capra JD
    J Exp Med; 1983 May; 157(5):1461-70. PubMed ID: 6189938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cells homozygous for two HLA-DR7-associated HLA-D specificities express highly similar DR molecules but different DQ molecules.
    Karr RW; Hsu SH; Bias WB
    Hum Immunol; 1986 Feb; 15(2):198-210. PubMed ID: 3081469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of MT3 antigens by two-dimensional gel electrophoresis, NH2-terminal amino acid sequence analysis, and southern blot analysis.
    Sorrentino R; Lillie J; Strominger JL
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3794-8. PubMed ID: 2582424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complexity of HLA-DS molecules. A homozygous cell line expresses multiple HLA-DS alpha chains.
    Karr RW; Alber C; Goyert SM; Silver J; Duquesnoy RJ
    J Exp Med; 1984 May; 159(5):1512-31. PubMed ID: 6425448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MT3 specificity resides on a novel human class II antigen distinct from the HLA-DR antigen and DC-like antigen.
    Yabe T; Suzuki M; Satake M; Juji T; Hamaguchi H
    Immunogenetics; 1984; 20(2):155-67. PubMed ID: 6205988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for polymorphism of MB3 antigens among three HLA-D clusters associated with HLA-DR4.
    Ikeda H; Kasahara M; Ogasawara K; Takenouchi T; Okuyama T; Ishikawa N; Wakisaka A; Kikuchi Y; Aizawa M
    Immunogenetics; 1984; 19(5):381-90. PubMed ID: 6202628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the MT3 molecule from HLA-DR4, 7, and w9 homozygous cell lines.
    Mukai R; Suzuki M; Yabe T; Hamaguchi H; Maeda H
    J Immunol; 1984 Dec; 133(6):3211-9. PubMed ID: 6436378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new supertypic HLA class II determinant (PL2) differentially expressed with DR7, DRw11(5), DRw13(w6), DRw14(w6), DR3, and DR2 and biochemically localized to DR7 molecules.
    Horibe K; Knowles RW; Dupont B
    Hum Immunol; 1986 May; 16(1):14-23. PubMed ID: 2423484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative expression of epitopes defined by murine monoclonal antibodies on DR molecules from different HLA haplotypes.
    Letarte M; Addis J; Iturbe S; Petsche D
    Biosci Rep; 1985; 5(10-11):923-31. PubMed ID: 2420387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new polymorphic determinant on HLA-DQ molecules.
    Shipp MA; Ahmed P; Kannapell CC; Ford JC; McCourt D; Leykam JF; Zacheis M; Bono C; Davie JM; Mustain E
    Hum Immunol; 1986 May; 16(1):24-37. PubMed ID: 2423485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HLA-DR4 family of haplotypes consists of series of distinct DR and DS molecules.
    Nepom GT; Nepom BS; Antonelli P; Mickelson E; Silver J; Goyert SM; Hansen JA
    J Exp Med; 1984 Feb; 159(2):394-404. PubMed ID: 6420500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The heavy chain of human B-cell alloantigen HLA-DS has a variable N-terminal region and a constant immunoglobulin-like region.
    Chang HC; Moriuchi T; Silver J
    Nature; 1983 Oct 27-Nov 2; 305(5937):813-5. PubMed ID: 6415485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of HLA-DR and HLA-DC/DS molecules in a patient with hairy cell leukemia: restoration of HLA-DC/DS expression by (12-0-tetradecanoyl phorbol-13-acetate), 5 azacytidine, and sodium butyrate.
    Faille A; Turmel P; Charron DJ
    Blood; 1984 Jul; 64(1):33-7. PubMed ID: 6203577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.